Over the counter drugs
Subtitle: gaps and potential vulnerabilities in the regulatory system : statement of Kwai-Cheung Chan, Director of Program Evaluation in Physical Systems Areas, Program Evaluation and Methodology Division, before the Subcommittee on Regulation, Business Opportunities and Energy, Committee on Small Business, House of Representatives
By: United States General Accounting Office.
Contributors: United States. General Accounting Office.
Series: Testimony -- GAO/T-PEMD-92-8.
Publisher: The Office; The Office [distributor
Published: 1992
Place of publication: [Washington, D.C.]; [Gaithersburg, MD] (P.O. Box 6015, Gaithersburg 20884-6015)
Language: eng
Format: Microform
Subjects: United States. -- Food and Drug Administration.; Drugs, Nonprescription -- Safety regulations -- United States.
Other titles: Gaps and potential vulnerabilities in the regulatory system.
Notes: Distributed to depository libraries in microfiche.

Shipping list no.: 92-2199-M.

"April 28, 1992."

Microfiche. [Washington, D.C.] : U.S. General Accounting Office, [1992?] 1 microfiche : negative.